More about

Hepatocellular Carcinoma

News
June 27, 2023
1 min read
Save

Behavioral data ‘has the potential’ to predict HCC in patients with hepatitis B

Behavioral data ‘has the potential’ to predict HCC in patients with hepatitis B

Scoring systems based on behavioral and clinical data outperformed existing scores in predicting risk for hepatocellular carcinoma in patients with chronic hepatitis B virus infection, according to data presented at the EASL Congress.

News
June 02, 2023
2 min read
Save

Patients report no quality-of-life issues with adjuvant regimen for high-risk liver cancer

Patients report no quality-of-life issues with adjuvant regimen for high-risk liver cancer

CHICAGO — Individuals with high-risk hepatocellular carcinoma undergoing curative-intent procedures did not experience clinically meaningful deterioration in quality of life or function after adjuvant therapy, phase 3 study results showed.

News
May 26, 2023
6 min watch
Save

VIDEO: Results of IMbrave050 trial ‘potentially practice-changing’

VIDEO: Results of IMbrave050 trial ‘potentially practice-changing’

In this video, Daneng Li, MD, a medical oncologist at City of Hope, discussed results from the Phase 3 IMbrave050 trial presented at American Association for Cancer Research Annual Meeting.

News
May 18, 2023
2 min read
Save

Immigrants with liver cancer survive longer than their U.S.-born counterparts

Immigrants with liver cancer survive longer than their U.S.-born counterparts

Foreign-born patients with hepatocellular carcinoma had higher survival rates than those born in the United States, according to data published in JNCI: Journal of the National Cancer Institute.

News
May 12, 2023
1 min read
Save

Significant drop in hepatocellular carcinoma cases reported in 2020 vs. pre-COVID years

Significant drop in hepatocellular carcinoma cases reported in 2020 vs. pre-COVID years

CHICAGO — Reported cases of hepatocellular carcinoma decreased significantly in 2020 compared with years before the COVID-19 pandemic, although there was minimal impact on tumor stage and patients receiving curative treatment.

News
May 10, 2023
2 min watch
Save

VIDEO: Neoadjuvant, adjuvant studies show promise in preventing HCC recurrence

VIDEO: Neoadjuvant, adjuvant studies show promise in preventing HCC recurrence

In this video, Thomas Marron, MD, PhD, discussed the larger implications of hepatocellular carcinoma treatments presented at American Association for Cancer Research Annual Meeting.

News
May 09, 2023
4 min watch
Save

VIDEO: Circulating tumor DNA levels could help predict hepatocellular carcinoma recurrence

VIDEO: Circulating tumor DNA levels could help predict hepatocellular carcinoma recurrence

In this video, Thomas Marron, MD, PhD, discussed data he presented on patients with liver cancer treated with neoadjuvant cemiplimab (Libtayo, Regeneron) at American Association for Cancer Research Annual Meeting.

News
May 09, 2023
4 min watch
Save

VIDEO: Following up IMbrave050 study will be important in hepatocellular carcinoma

VIDEO: Following up IMbrave050 study will be important in hepatocellular carcinoma

In this video, Thomas Marron, MD, PhD, discussed results from the phase 3 IMbrave050 study, presented at American Association for Cancer Research Annual Meeting.

News
May 08, 2023
4 min watch
Save

VIDEO: IMbrave050 trial shows ‘exciting’ results in hepatocellular carcinoma

VIDEO: IMbrave050 trial shows ‘exciting’ results in hepatocellular carcinoma

In this video, Ahmed Kaseb, MD, CMQ, discussed results from the phase 3 IMbrave050 trial, presented at American Association for Cancer Research Annual Meeting.

News
May 05, 2023
2 min watch
Save

VIDEO: IMbrave050 study a ‘huge breakthrough’ in hepatocellular carcinoma

VIDEO: IMbrave050 study a ‘huge breakthrough’ in hepatocellular carcinoma

In this video, James Cleary, MD, PhD, a medical oncologist at Dana-Farber Cancer Institute, discussed results from the phase 3 IMbrave050 trial, presented at American Association for Cancer Research Annual Meeting.

View more